Gerald Willimsky

4.2k total citations · 1 hit paper
49 papers, 2.0k citations indexed

About

Gerald Willimsky is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Gerald Willimsky has authored 49 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Immunology, 29 papers in Oncology and 17 papers in Molecular Biology. Recurrent topics in Gerald Willimsky's work include Immunotherapy and Immune Responses (29 papers), CAR-T cell therapy research (17 papers) and Immune Cell Function and Interaction (16 papers). Gerald Willimsky is often cited by papers focused on Immunotherapy and Immune Responses (29 papers), CAR-T cell therapy research (17 papers) and Immune Cell Function and Interaction (16 papers). Gerald Willimsky collaborates with scholars based in Germany, United States and Croatia. Gerald Willimsky's co-authors include Thomas Blankenstein, Mohamed A. Marahiel, G. Fischer, Holger Bang, Shabnam Shalapour, Donna E. Hansel, Joan Font-Burgada, Zhenyu Zhong, Lukas Kenner and Massimo Ammirante and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Gerald Willimsky

48 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy

2015 429 citations Gerald Willimsky et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gerald Willimsky Germany	23	1.2k	981	638	245	110	49	2.0k
Charles A. Nicolette United States	24	871 0.7×	579 0.6×	1.3k 2.0×	216 0.9×	172 1.6×	51	2.1k
C Rugarli Italy	23	2.1k 1.7×	476 0.5×	1.1k 1.7×	203 0.8×	151 1.4×	92	3.1k
Alfonso R. Sánchez-Paulete Spain	21	1.5k 1.2×	1.3k 1.3×	402 0.6×	176 0.7×	120 1.1×	27	2.1k
Gábor Pál Hungary	25	761 0.6×	193 0.2×	736 1.2×	102 0.4×	86 0.8×	62	1.9k
Marja Nieuwland Netherlands	17	634 0.5×	845 0.9×	843 1.3×	101 0.4×	153 1.4×	27	1.9k
Monica C. Panelli United States	32	1.8k 1.5×	1.2k 1.3×	1.2k 1.8×	223 0.9×	133 1.2×	75	3.0k
Ignacio Moraga United States	22	1.3k 1.1×	957 1.0×	680 1.1×	116 0.5×	44 0.4×	34	2.2k
John C. Castle United States	15	1.5k 1.2×	1.2k 1.3×	1.2k 1.8×	210 0.9×	269 2.4×	21	2.8k
Zachary C. Hartman United States	27	908 0.7×	1.0k 1.0×	1.2k 1.9×	549 2.2×	118 1.1×	68	2.5k

Countries citing papers authored by Gerald Willimsky

Since Specialization

Citations

This map shows the geographic impact of Gerald Willimsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald Willimsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald Willimsky more than expected).

Fields of papers citing papers by Gerald Willimsky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerald Willimsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald Willimsky. The network helps show where Gerald Willimsky may publish in the future.

Co-authorship network of co-authors of Gerald Willimsky

This figure shows the co-authorship network connecting the top 25 collaborators of Gerald Willimsky. A scholar is included among the top collaborators of Gerald Willimsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerald Willimsky. Gerald Willimsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Leisegang, Matthias, Cäcilia Freund, Gerald Willimsky, et al.. (2025). A CD22-specific T-cell receptor enables effective adoptive T-cell therapy for B-cell malignancies. Blood. 147(10). 1058–1069.

Hansmann, Leo, Guoshuai Cao, Jun Huang, et al.. (2025). Selection of therapeutically effective T-cell receptors from the diverse tumor-bearing repertoire. Journal for ImmunoTherapy of Cancer. 13(5). e011351–e011351. 2 indexed citations

Drude, Natascha, Stephan P. Rosshart, Andreas Diefenbach, et al.. (2024). A facility for laboratory mice with a natural microbiome at Charité – Universitätsmedizin Berlin. Lab Animal. 53(12). 351–354. 1 indexed citations

Papafotiou, George, et al.. (2023). Targeting the recurrent Rac1P29S neoepitope in melanoma with heterologous high-affinity T cell receptors. Frontiers in Immunology. 14. 1119498–1119498. 3 indexed citations

Willimsky, Gerald, Leo Hansmann, Thomas Blankenstein, et al.. (2022). Isolation of Neoantigen-Specific Human T Cell Receptors from Different Human and Murine Repertoires. Cancers. 14(7). 1842–1842. 2 indexed citations

Papafotiou, George, et al.. (2022). H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2⁺ patients with diffuse midline glioma. Journal for ImmunoTherapy of Cancer. 10(10). e005535–e005535. 11 indexed citations

Rehm, Armin, Cornelius Fischer, Kerstin Gerlach, et al.. (2022). EBAG9 controls CD8+ T cell memory formation responding to tumor challenge in mice. JCI Insight. 7(11). 2 indexed citations

Menzel, Lutz, Vedran Franke, Michael Grau, et al.. (2021). Lymphocyte access to lymphoma is impaired by high endothelial venule regression. Cell Reports. 37(4). 109878–109878. 12 indexed citations

Willimsky, Gerald, George Papafotiou, Andrean Goede, et al.. (2021). In vitro proteasome processing of neo-splicetopes does not predict their presentation in vivo. eLife. 10. 12 indexed citations

10.

Keller, Christin, Anja A. Kühl, Ana Textor, et al.. (2018). ERAP1-Dependent Antigen Cross-Presentation Determines Efficacy of Adoptive T-cell Therapy in Mice. Cancer Research. 78(12). 3243–3254. 11 indexed citations

11.

Gavvovidis, Ioannis, Matthias Leisegang, Gerald Willimsky, et al.. (2018). Targeting Merkel Cell Carcinoma by Engineered T Cells Specific to T-Antigens of Merkel Cell Polyomavirus. Clinical Cancer Research. 24(15). 3644–3655. 24 indexed citations

12.

Schlenker, Ramona, Matthias Leisegang, Svenja Rühland, et al.. (2017). Chimeric PD-1:28 Receptor Upgrades Low-Avidity T cells and Restores Effector Function of Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy. Cancer Research. 77(13). 3577–3590. 33 indexed citations

13.

Miller, Natalie, Candice D. Church, Lichun Dong, et al.. (2017). Tumor-Infiltrating Merkel Cell Polyomavirus-Specific T Cells Are Diverse and Associated with Improved Patient Survival. Cancer Immunology Research. 5(2). 137–147. 71 indexed citations

14.

Charo, Jehad, et al.. (2010). In Vivo Imaging of an Inducible Oncogenic Tumor Antigen Visualizes Tumor Progression and Predicts CTL Tolerance. The Journal of Immunology. 184(6). 2930–2938. 12 indexed citations

15.

Willimsky, Gerald, Melinda Czéh, Christoph Loddenkemper, et al.. (2008). Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness. The Journal of Experimental Medicine. 205(7). 1687–1700. 88 indexed citations

16.

Preiß, Susanne, Thomas Kammertoens, C. Lampert, Gerald Willimsky, & Thomas Blankenstein. (2005). Tumor‐induced antibodies resemble the response to tissue damage. International Journal of Cancer. 115(3). 456–462. 24 indexed citations

17.

Willimsky, Gerald & Thomas Blankenstein. (2005). Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance. Nature. 437(7055). 141–146. 338 indexed citations

18.

Schendel, D. J., Bernhard Frankenberger, S Cayeux, et al.. (2000). Expression of B7.1 (CD80) in a renal cell carcinoma line allows expansion of tumor-associated cytotoxic T lymphocytes in the presence of an alloresponse. Gene Therapy. 7(23). 2007–2014. 33 indexed citations

19.

Schindelin, Hermann, Michael Herrler, Gerald Willimsky, Mohamed A. Marahiel, & Udo Heinemann. (1992). Overproduction, crystallization, and preliminary X‐ray diffraction studies of the major cold shock protein from Bacillus subtilis, CspB. Proteins Structure Function and Bioinformatics. 14(1). 120–124. 43 indexed citations

20.

Willimsky, Gerald, Holger Bang, G. Fischer, & Mohamed A. Marahiel. (1992). Characterization of cspB, a Bacillus subtilis inducible cold shock gene affecting cell viability at low temperatures. Journal of Bacteriology. 174(20). 6326–6335. 204 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact